24/7 Customer Support

Japan Bioanalytical Testing Services Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2030

Japan Bioanalytical Testing Services Market – (By Test Type - Cell-based Assays, Virology Testing, Species-specific Viral PCR Assays, Method Development Optimization and Validation, and Others; By Molecule Type - Small Molecule Bioanalysis, Large Molecule Bioanalysis, and Others; By Application – Oncology, Neurology, Infectious Diseases, and Others; By End User - Pharma & Biotechnology Companies, Contract Research Organizations, and Others) - Industry Dynamics, Market Size and Opportunity Forecast, 2030

  • Published On: 19-May-2022  |  Format: pdfpowerpointexcel  |  Report ID: AA0522242
    Delivery: 2 to 4 Hours

FREQUENTLY ASKED QUESTIONS

The Japan Bioanalytical Testing Service Market was valued at US$ 63.5 Mn in 2021.

The main impact of bioanalysis in the pharmaceutical industry of Japan is to obtain a quantitative measure of the drug and its metabolites.

Bioanalysis is a quantitative measurement of a compound (drug) or its metabolite in biological fluids such as blood, plasma, serum, urine, or tissue extracts.

The Japan Bioanalytical Testing Service Market is projected to rise at a CAGR of 11.6% over the forecast period. 

The market is majorly driven by factors such as increasing preference for outsourcing analytical testing and rising adoption of the quality by design approach.

The challenges of software validation and high technology implementation cost are hindering the market growth. 

The growing prevalence of infectious diseases is providing a lucrative opportunity for market growth.

Cell-based assays dominates the market in 2021.

In terms of application, the oncology segment leads the bioanalytical testing service market in 2021.

Pharma and biotechnologies companies are the highest end-users in the Japan Bioanalytical Testing Service Market.

The key players in the Japan Bioanalytical Testing Service Market are Syneos Health Inc., Laboratory Corporation of America, Charles River Laboratories Inc, ICON Plc, among others.